Skip to content

Clinical trials

Cognition Disorders trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cognition Disorders Country / region: Canada Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20052
20071
20111
20121
20133
20143
20161
20182
20193
20211
20222
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Recruiting2
Unknown status2
Withdrawn2
Terminated1
Enrolling by invitation1
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's3
Sunnybrook Health Sciences Centre3
University of Southern California3
FORUM Pharmaceuticals Inc2
Alzheimer's Disease Cooperative Study (ADCS)1
AstraZeneca1
Brain and Cognition Discovery Foundation1
CancerCare Manitoba1
Centre for Addiction and Mental Health1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cognition Disorders24
Cognitive Dysfunction10
Schizophrenia5
Alzheimer Disease4
Dementia3
Pick Disease of the Brain3
Plaque, Amyloid3
Stress Disorders, Post-Traumatic3
Brain Neoplasms2
Delirium2

Trials

Showing 51 to 24 of 24. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.